Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 4 (2008), Issue 6 (June)

1. The forgotten team member: meeting the needs of oncology support staff.
   Oncologist, 13(5): 530-8. [Abstract] [Full-text]
2. Patient misidentification in oncology care.
   Clin J Oncol Nurs, 12(3): 495-8. [Abstract] [Full-text]
3. Reiki as a clinical intervention in oncology nursing practice.
   Clin J Oncol Nurs, 12(3): 489-94. [Abstract] [Full-text]
4. Oncology nurses' perceptions of barriers to discussion of fertility preservation with patients with cancer.
   Clin J Oncol Nurs, 12(3): 467-76. [Abstract] [Full-text]
5. Symptom management issues in oncology nursing.
   Nurs Clin North Am, 43(2): 205-20. [Abstract] [Full-text]
6. A clinical pathway for postoperative management and early patient discharge: does it work in gynecologic oncology?
   Am J Obstet Gynecol. [Abstract] [Full-text]
7. The future of radiation oncology: the evolution, diversification, and survival of the specialty.
   Semin Radiat Oncol, 18(3): 207-13. [Abstract] [Full-text]
8. Measuring the quality of care in radiation oncology.
   Semin Radiat Oncol, 18(3): 201-6. [Abstract] [Full-text]
9. Development of clinical trials in a cooperative group setting: the eastern cooperative oncology group.
   Clin Cancer Res, 14(11): 3427-33. [Abstract] [Full-text]
10. Survival of children with cancer in Italy, 1989-98. A report from the hospital based registry of the Italian Association of Paediatric Haematology and Oncology (AIEOP).
    Eur J Cancer, 44(9): 1282-1289. [Abstract] [Full-text]
11. Primary renal sarcomas in the Intergroup Rhabdomyosarcoma Study Group (IRSG) experience, 1972-2005: A report from the Children's Oncology Group.
    Pediatr Blood Cancer. [Abstract] [Full-text]
12. Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.
    Brain Pathol, 18(3): 360-9. [Abstract] [Full-text]
13. Clinician and therapist perceptions on radiation therapist-led treatment reviews in radiation oncology practice.
    Radiother Oncol. [Abstract] [Full-text]
14. Stress spectrum disorders in oncology.
    Curr Opin Oncol, 20(4): 378-85. [Abstract] [Full-text]
15. Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.
    Gynecol Oncol, 109(3): 323-8. [Abstract] [Full-text]
16. Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology.
    Trends Pharmacol Sci, 29(6): 302-13. [Abstract] [Full-text]
17. Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study.
    Gynecol Oncol, 109(3): 353-8. [Abstract] [Full-text]
18. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
    Gynecol Oncol, 109(3): 388-93. [Abstract] [Full-text]
19. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.
    Gynecol Oncol, 109(3): 329-34. [Abstract] [Full-text]
20. Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group study.
    Hum Pathol, 39(6): 866-74. [Abstract] [Full-text]
21. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology.
    J Clin Oncol, 26(17): 2828-38. [Abstract] [Full-text]
22. Head-and-Neck Target Delineation Among Radiation Oncology Residents After a Teaching Intervention: A Prospective, Blinded Pilot Study.
    Int J Radiat Oncol Biol Phys. [Abstract] [Full-text]
23. Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century.
    Radiother Oncol. [Abstract] [Full-text]
24. Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging.
    Am J Obstet Gynecol, 198(6): 679.e1-9; discussion 679.e9-10. [Abstract] [Full-text]
25. Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802): a trial of the Eastern Cooperative Oncology Group.
    Cancer, 112(12): 2671-5. [Abstract] [Full-text]
26. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology.
    Eur Radiol. [Abstract] [Full-text]
27. Clinical and prognostic features of plasmacytomas: A multicenter study of Turkish Oncology Group-Sarcoma Working Party.
    Am J Hematol. [Abstract] [Full-text]
28. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
    Blood, 111(12): 5477-85. [Abstract] [Full-text]
29. Serum protein expression profiling in pediatric Hodgkin lymphoma: a report from the Children's Oncology Group.
    Pediatr Blood Cancer, 51(2): 216-21. [Abstract] [Full-text]
30. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee.
    Pediatr Blood Cancer, 51(2): 163-70. [Abstract] [Full-text]
31. Internet-Based Survey Evaluating Use of Pain Medications and Attitudes of Radiation Oncology Patients Toward Pain Intervention.
    Int J Radiat Oncol Biol Phys. [Abstract] [Full-text]
32. To tell or not to tell: attitudes of Chinese oncology nurses towards truth telling of cancer diagnosis.
    J Clin Nurs. [Abstract] [Full-text]
33. Surgical strategies in the management of ecthyma gangrenosum in paediatric oncology patients.
    Pediatr Surg Int, 24(7): 793-797. [Abstract] [Full-text]
34. Shedding light on vitamin d and integrative oncology.
    Integr Cancer Ther, 7(2): 81-9. [Abstract] [Full-text]
35. An International Pilot Study of Oncology Physicians' Opinions and Practices on Complementary and Alternative Medicine (CAM).
    Integr Cancer Ther, 7(2): 70-5. [Abstract] [Full-text]
36. The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients.
    Support Care Cancer. [Abstract] [Full-text]
37. Smoking behavior and patient education practices of oncology nurses in six countries.
    Eur J Oncol Nurs. [Abstract] [Full-text]
38. Therapeutic potential of novel selective-spectrum kinase inhibitors in oncology.
    Expert Opin Investig Drugs, 17(7): 1013-28. [Abstract] [Full-text]
39. Opinions concerning euthanasia, life-sustaining treatment and acceleration of death: results of an Italian Association of Medical Oncology (AIOM) survey.
    Ann Oncol. [Abstract] [Full-text]
40. How do radiation oncology health professionals inform breast cancer patients about the medical and technical aspects of their treatment?
    Radiother Oncol. [Abstract] [Full-text]
41. A phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trial (KDOG 0501).
    Radiother Oncol, 87(3): 398-404. [Abstract] [Full-text]
42. A case-control study of childhood brain tumors and fathers' hobbies: a Children's Oncology Group study.
    Cancer Causes Control. [Abstract] [Full-text]
43. The ethics of phase 0 oncology trials.
    Clin Cancer Res, 14(12): 3692-7. [Abstract] [Full-text]
44. The relationship between nursing leadership and nurses' job satisfaction in Canadian oncology work environments.
    J Nurs Manag, 16(5): 508-18. [Abstract] [Full-text]
45. Cancer patients' satisfaction with care in traditional and innovative ambulatory oncology clinics.
    J Nurs Care Qual, 23(3): 251-7. [Abstract] [Full-text]
46. Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studies.
    Am J Obstet Gynecol. [Abstract] [Full-text]
47. Demographic, Clinical, and Pain Characteristics Are Associated With Average Pain Severity Groups in a Sample of Oncology Outpatients.
    J Pain. [Abstract] [Full-text]
48. Ten-year survival of children with acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Leuk Lymphoma, 49(6): 1142-54. [Abstract] [Full-text]
49. Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
    Cancer Invest, 26(5): 491-8. [Abstract] [Full-text]
50. Impact of music on pediatric oncology outpatients.
    Pediatr Res, 64(1): 105-9. [Abstract] [Full-text]
51. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
    Jpn J Clin Oncol, 38(6): 432-7. [Abstract] [Full-text]
52. Stopping a trial early in oncology: for patients or for industry?
    Ann Oncol, 19(7): 1347-53. [Abstract] [Full-text]
53. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients.
    Support Care Cancer. [Abstract] [Full-text]
54. Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?
    Nat Clin Pract Oncol, 5(7): 378-91. [Abstract] [Full-text]
55. Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: a Gynecologic Oncology Group study.
    Gynecol Oncol, 110(1): 60-4. [Abstract] [Full-text]
56. Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
    Gynecol Oncol, 110(1): 87-92. [Abstract] [Full-text]
57. Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Gynecol Oncol, 110(1): 65-70. [Abstract] [Full-text]
58. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study.
    Gynecol Oncol, 110(1): 76-82. [Abstract] [Full-text]
59. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2008.
    Intern Med J, 38(6): 457-467. [Abstract] [Full-text]
60. Characteristics and outcome of pediatric patients enrolled in phase I oncology trials.
    Oncologist, 13(6): 679-89. [Abstract] [Full-text]
61. The Introduction of Single Best Answer Questions as a Test of Knowledge in the Final Examination for the Fellowship of the Royal College of Radiologists in Clinical Oncology.
    Clin Oncol (R Coll Radiol). [Abstract] [Full-text]
62. The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: Current clinical trials.
    Gynecol Oncol. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.